BioSpace News Archive

The global gene amplification technologies market size is poised to reach USD 300.28 million by 2023, according to a new report by Technavio, progressing at a CAGR of 6% during the forecast period.

AquiSense Technologies, the world leader in ultraviolet (UV) LED disinfection technology, has participated in ten distinct aerospace projects.

Family Research Council applauds the Republican Minority in the U.S. House of Representatives for scheduling a hearing on the Born Alive Abortion Survivors Protection Act. Speaker Nancy Pelosi and House leadership have blocked a vote on the bill more than 80 times and have refused to schedule a hearing or sign the discharge petition for the bill.

Events gathered patients, families and providers who have been affected by or treat Congenital Hyperinsulinism

The latest in a series of videos by VITAS® Healthcare, the nation’s leading provider of end-of-life care, chronicles the advances in hospice technology—from handwritten intake forms detailing patient information to today’s use of virtual/augmented reality therapy for patients—and shows the many ways the company has innovated care at the patient bedside over the last four decades.

Pack4U announces a joint strategy with Catalyst Healthcare and Northwest Telepharmacy to match Ontario pharmacists with technology, services and clinical support related to medication management.

The Hyundai Hope On Wheels non-profit embarks on a nationwide tour this September during Childhood Cancer Awareness Month to award new grants for pediatric cancer, surpassing $160 million in lifetime funding for research

Encompass Health Corp. announces the opening of its 133rd inpatient rehabilitation hospital, Encompass Health Rehabilitation Hospital of Katy.

Massachusetts Coalition for Serious Illness Care is pleased to appoint Anna Gosline as its new executive director

With today’s launch of the open comment period for the draft “Biomarker Testing for the Diagnosis of Diffuse Gliomas” evidence-based guideline, the College of American Pathologists (CAP) joins forces across the clinical care team to improve how adult and pediatric patients with these tumors are diagnosed and treated.